Anteris Technologies Ltd (AVR.AX)
AUD 9.04
(5.24%)
AUD 9.04
(5.24%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 2.51 Million AUD | -63.31% |
| 2022 | -21.58 Million AUD | -144.91% |
| 2021 | -8.81 Million AUD | -7.45% |
| 2020 | -8.2 Million AUD | 40.99% |
| 2019 | -13.89 Million AUD | -213.45% |
| 2018 | 12.24 Million AUD | -8.15% |
| 2017 | 13.33 Million AUD | 323.37% |
| 2016 | -5.97 Million AUD | -216.57% |
| 2015 | 5.12 Million AUD | 84.24% |
| 2014 | 2.78 Million AUD | -9.08% |
| 2013 | 3.05 Million AUD | -16.09% |
| 2012 | 3.64 Million AUD | 19.55% |
| 2011 | 3.04 Million AUD | 1.9% |
| 2010 | 2.99 Million AUD | 0.0% |
| 2009 | - AUD | 0.0% |
| 2008 | - AUD | 0.0% |
| 2007 | - AUD | 0.0% |
| 2006 | - AUD | 0.0% |
| 2005 | - AUD | 0.0% |
| 2004 | - AUD | 0.0% |
| 2003 | - AUD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 890.65 Thousand AUD | 0.0% |
| 2023 Q4 | -23.38 Million AUD | 0.0% |
| 2023 Q2 | -11.86 Million AUD | 0.0% |
| 2023 FY | -35.24 Million AUD | -63.31% |
| 2022 Q4 | -12.1 Million AUD | 0.0% |
| 2022 Q2 | -7.62 Million AUD | 0.0% |
| 2022 FY | -21.58 Million AUD | -144.91% |
| 2021 FY | -8.81 Million AUD | -7.45% |
| 2021 Q2 | -4.41 Million AUD | 0.0% |
| 2021 Q4 | -4.4 Million AUD | 0.0% |
| 2020 Q2 | -4.58 Million AUD | 0.0% |
| 2020 Q4 | -3.61 Million AUD | 0.0% |
| 2020 FY | -8.2 Million AUD | 40.99% |
| 2019 Q2 | -7.52 Million AUD | 0.0% |
| 2019 Q4 | -6.37 Million AUD | 0.0% |
| 2019 FY | -13.89 Million AUD | -213.45% |
| 2018 Q4 | 6.22 Million AUD | 0.0% |
| 2018 FY | 12.24 Million AUD | -8.15% |
| 2018 Q2 | 6.02 Million AUD | 0.0% |
| 2017 FY | 13.33 Million AUD | 323.37% |
| 2017 Q2 | 4.49 Million AUD | 0.0% |
| 2016 Q2 | 2.83 Million AUD | 0.0% |
| 2016 Q4 | 5.79 Million AUD | 0.0% |
| 2016 FY | -5.97 Million AUD | -216.57% |
| 2015 Q4 | 2.28 Million AUD | 0.0% |
| 2015 FY | 5.12 Million AUD | 84.24% |
| 2015 Q2 | 786.59 Thousand AUD | 0.0% |
| 2014 FY | 2.78 Million AUD | -9.08% |
| 2014 Q2 | 1.09 Million AUD | 0.0% |
| 2014 Q4 | 1.99 Million AUD | 0.0% |
| 2013 FY | 3.05 Million AUD | -16.09% |
| 2013 Q4 | 1.86 Million AUD | 0.0% |
| 2013 Q2 | 1.5 Million AUD | 0.0% |
| 2012 Q2 | 762.06 Thousand AUD | 0.0% |
| 2012 Q1 | 762.06 Thousand AUD | -0.0% |
| 2012 FY | 3.64 Million AUD | 19.55% |
| 2012 Q4 | 2.03 Million AUD | 167.29% |
| 2012 Q3 | 762.06 Thousand AUD | -0.0% |
| 2011 Q2 | 747.88 Thousand AUD | 0.0% |
| 2011 Q3 | 747.88 Thousand AUD | -0.0% |
| 2011 Q4 | 762.06 Thousand AUD | 1.9% |
| 2011 FY | 3.04 Million AUD | 1.9% |
| 2011 Q1 | 747.88 Thousand AUD | -0.0% |
| 2010 FY | 2.99 Million AUD | 0.0% |
| 2010 Q3 | - AUD | 0.0% |
| 2010 Q4 | 747.88 Thousand AUD | 0.0% |
| 2010 Q2 | - AUD | 0.0% |
| 2010 Q1 | - AUD | 0.0% |
| 2009 Q3 | - AUD | 0.0% |
| 2009 Q4 | - AUD | 0.0% |
| 2009 Q2 | - AUD | 0.0% |
| 2009 FY | - AUD | 0.0% |
| 2009 Q1 | - AUD | 0.0% |
| 2008 Q3 | - AUD | 0.0% |
| 2008 FY | - AUD | 0.0% |
| 2008 Q4 | - AUD | 0.0% |
| 2008 Q2 | - AUD | 0.0% |
| 2008 Q1 | - AUD | 0.0% |
| 2007 Q1 | - AUD | 0.0% |
| 2007 Q4 | - AUD | 0.0% |
| 2007 FY | - AUD | 0.0% |
| 2007 Q3 | - AUD | 0.0% |
| 2007 Q2 | - AUD | 0.0% |
| 2006 Q3 | - AUD | 0.0% |
| 2006 Q4 | - AUD | 0.0% |
| 2006 FY | - AUD | 0.0% |
| 2006 Q1 | - AUD | 0.0% |
| 2006 Q2 | - AUD | 0.0% |
| 2005 Q4 | - AUD | 0.0% |
| 2005 FY | - AUD | 0.0% |
| 2005 Q1 | - AUD | 0.0% |
| 2005 Q2 | - AUD | 0.0% |
| 2005 Q3 | - AUD | 0.0% |
| 2004 Q3 | - AUD | 0.0% |
| 2004 FY | - AUD | 0.0% |
| 2004 Q2 | - AUD | 0.0% |
| 2004 Q4 | - AUD | 0.0% |
| 2004 Q1 | - AUD | 0.0% |
| 2003 FY | - AUD | 0.0% |
| 2003 Q4 | - AUD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| 4DMedical Limited | 3.51 Million AUD | 28.439% |
| Adherium Limited | -640.83 Thousand AUD | 492.797% |
| Aroa Biosurgery Limited | 53.98 Million AUD | 95.338% |
| Atomo Diagnostics Limited | 1.43 Million AUD | -75.205% |
| Control Bionics Limited | 3.67 Million AUD | 31.464% |
| CardieX Limited | 10.1 Million AUD | 75.097% |
| Compumedics Limited | 26.06 Million AUD | 90.344% |
| Cochlear Limited | 1.69 Billion AUD | 99.852% |
| CleanSpace Holdings Limited | 11.35 Million AUD | 77.84% |
| Cyclopharm Limited | 4.49 Million AUD | 44.029% |
| EMVision Medical Devices Ltd | 11.21 Million AUD | 77.564% |
| Nova Eye Medical Limited | 20.19 Million AUD | 87.534% |
| HeraMED Limited | -504.09 Thousand AUD | 599.347% |
| Imricor Medical Systems, Inc. | -1.99 Million AUD | 226.308% |
| ImpediMed Limited | 9 Million AUD | 72.047% |
| InhaleRx Limited | 1.2 Million AUD | -109.06% |
| LBT Innovations Limited | -2.91 Million AUD | 186.293% |
| Micro-X Limited | 5.73 Million AUD | 56.124% |
| Neurotech International Limited | -5867.00 AUD | 43004.057% |
| OncoSil Medical Limited | 55.63 Thousand AUD | -4424.7% |
| PolyNovo Limited | 36.08 Million AUD | 93.024% |
| Respiri Limited | 456.91 Thousand AUD | -450.909% |
| SomnoMed Limited | 55.13 Million AUD | 95.434% |
| Universal Biosensors, Inc. | 4.28 Million AUD | 41.255% |
| Uscom Limited | 3.11 Million AUD | 19.21% |
| Visioneering Technologies, Inc. | -271.11 Thousand AUD | 1028.452% |